Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

820 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-19

Study Completion Date

2022-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background and significance: Treatment with opioid pain medications (like hydrocodone and morphine) is common for severe pain, but studies show these medications may not always help and can cause serious problems. High daily doses of opioids can be especially unsafe. To help patients with chronic pain have better quality of life and avoid medication toxicity, health care teams need to manage pain while helping patients reduce opioid medication doses to safer levels.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Primary Care Intervention to Reduce Prescription Opioid Overdoses

NCT02464410

Pain Drug Overdose Opioid Use Disorders

COMPLETED NA

Pain and Opioids: Integrated Treatment In Veterans

NCT04648228

Chronic Pain Opioid-use Disorder Opioids; Harmful Use

ACTIVE_NOT_RECRUITING NA

Health Outcomes From Opioid Therapy for Chronic Pain

NCT00495404

Chronic Pain Behavior, Addictive

COMPLETED NA

Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder

NCT06086275

Opioid Use Disorder

COMPLETED PHASE1

Better Options for Chronic Cancer Pain

NCT06574009

Chronic Pain Cancer Survivor Opioid Dependence

RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study aims: This study will test which of two pain treatment strategies is better for managing pain and helping patients improve safety of opioid medication. For patients on high opioid doses who want to reduce, this study will also test whether offering an extra option for tapering (buprenorphine-naloxone) helps them succeed. Finally, the study will examine patients' and clinicians' experiences with the interventions.

Study description: The study will compare two treatment strategies among patients with pain who are taking long-term opioid pain medications prescribed by VA healthcare facilities across the country. Patients who wish to enter the study will be assigned by chance to telecare collaborative management (TCM) or integrated pain team (IPT). TCM involves a pharmacist and supervising physician working together to find the best medication options for each individual patient. In IPT, a team of clinicians focuses on non-medication pain management options, in addition to pain medication.

All participants will be asked to stay in the study for 12 months. Patients for whom it would be unsafe to participate will not be invited to join. With either treatment strategy, TCM or IPT, participants will have individualized pain care tailored to their needs and preferences. Participants on high opioid medication doses who want to reduce their opioid medication dose will be assigned by chance to get either a regular step-wise taper or a choice between a regular taper or switching to a different medication (buprenorphine-naloxone).

At the end of the study, the two treatment strategies will be compared to see which worked better to (1) decrease pain severity and (2) reduce opioid medication dose. Other outcomes important to patients will also be tracked. These include quality of life, sleep, fatigue, depression, anxiety, and side effects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Intervention Type DRUG

Option of using buprenorphine-naloxone to assist with opioid dose reduction or discontinuation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medication management

Individualized management of medications for pain

Intervention Type OTHER

Non-pharmacological pain management

Individualized management of non-medication pain treatment approaches

Intervention Type OTHER

Buprenorphine-Naloxone

Option of using buprenorphine-naloxone to assist with opioid dose reduction or discontinuation

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Moderate or high-dose long-term opioid therapy (≥ 20 ME mg daily for at least 3 months) for chronic pain
* Chronic pain of at least moderate severity (defined as pain that is present every or nearly every day for ≥ 6 months and with a score on the PEG 3-item pain measure of ≥ 5)

Exclusion Criteria

* Dementia diagnosis
* Unstable or severe untreated psychiatric disorder, including severe untreated substance use disorder or active suicidal ideation
* Unstable or end-stage medical disease that would interfere with participation, including cancer requiring active treatment and life expectancy \< 12 months
* Documentation of suspected controlled substance diversion
* Inability to communicate by telephone

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No